SEKISUI Diagnostics
William Faranda has extensive experience in business development and strategic roles within the diagnostics and biopharmaceutical industries. Currently serving as Vice President of Strategy and Business Development at Sekisui Diagnostics, LLC since 1991, William has been instrumental in driving the company's strategic initiatives. Prior to this role, William held the position of Sr. Director of Business Development at Genzyme from September 1991 to February 2011, where significant contributions were made to the organization's growth and development strategies.
SEKISUI Diagnostics
4 followers
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry reagents • Coagulation reagents • Point-of-care rapid tests and immunoassay system • Enzymes and specialty biochemicals